How do you pay?
How many capsules?

How to pay the least

Lowest without a membership

$22.33 for 30 capsules delivered ($17.08 plus $5.25 shipping)

Generic selegiline 5 mg from Cost Plus Drugs, by mail

What to do

  1. Make a free account on costplusdrugs.com. Ask your prescriber to send the prescription there, or Cost Plus Drugs can transfer it.Open Cost Plus Drugs 
  2. Order generic selegiline 5 mg. It comes by mail.

Other ways

Need it today? $30.72 for 30 capsules with the free Team Cuban Card, at pharmacies that take it. Get the free card and show it there.

See the price and get the card 

With a membership $14.30 for 30 capsules from Amazon Pharmacy, by mail ($139 a year).

Open Amazon Pharmacy 

A regular generic has the same active ingredient as Eldepryl, and the FDA requires it to work the same way.

See every pharmacy’s price

Compare every option

Brand name

Eldepryl itself isn’t sold as a prescription anymore.

Not soldNo longer sold

Authorized generic

One was sold before, but not anymore.

Not soldNo longer sold

Regular generic

Same active ingredient as Eldepryl. Fillers and dyes can differ.

Cash price$22.33for 30 capsules at Cost Plus Drugs, with shipping
Where to buy it and who makes it

Where to buy it

Pharmacies’ own cash prices for generic selegiline, lowest first.

Pick up in storeDelivered

From each pharmacy’s own site, read November 17, 2026. Confirm the price before you fill.

About these prices

Prices change, can differ by store and state, and may depend on the strength and how many you take. With insurance, ask what your plan charges; it can be less.

Who makes it

3 companies sell a generic of Eldepryl that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.

  • Apotex5 mg

    Has lactose · Has a dye: FD&C Blue No. 1

    How it looks, what’s in it, NDCs

    5 mg White and blue, capsule, 16 mm, marked “APO / 055”

    PackageNDC
    Bottle of 6060505-0055-1
    Bottle of 50060505-0055-3
    Bottle of 100060505-0055-2

    Inactive ingredients: anhydrous lactose, anhydrous citric acid, microcrystalline cellulose, stearic acid, talc, gelatin, FD&C Blue No. 1, titanium dioxide, ammonia, ferrosoferric oxide, alcohol, isopropyl alcohol, potassium hydroxide, propylene glycol, water, shellac, butyl alcohol

    FDA label

  • Novitium Pharma5 mg

    Has lactose · Has a dye: FD&C Red No. 40

    How it looks, what’s in it, NDCs

    5 mg White, capsule, 16 mm, marked “Novitium5mg / 504”

    PackageNDC
    Bottle of 6070954-504-10
    Bottle of 100070954-504-20

    Inactive ingredients: anhydrous citric acid, lactose monohydrate, cellulose, microcrystalline, magnesium stearate, gelatin, titanium dioxide, shellac, alcohol, isopropyl alcohol, butyl alcohol, propylene glycol, sodium hydroxide, povidone, FD&C Red No. 40

    FDA label

  • Rising Pharma Holdings5 mg

    Has lactose

    How it looks, what’s in it, NDCs

    5 mg White and blue, capsule, 16 mm, marked “P / 659”

    PackageNDC
    Bottle of 6016571-659-06
    Bottle of 50016571-659-50

    Inactive ingredients: anhydrous citric acid, anhydrous lactose, cellulose, microcrystalline, magnesium stearate, silicon dioxide

    FDA label

Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.

What it’s used for

What the FDA label says

Selegiline capsules, USP are indicated as an adjunct in the management of Parkinsonian patients being treated with levodopa/carbidopa who exhibit deterioration in the quality of their response to this therapy. There is no evidence from controlled studies that selegiline has any beneficial effect in the absence of concurrent levodopa therapy.

Evidence supporting this claim was obtained in randomized controlled clinical investigations that compared the effects of added selegiline or placebo in patients receiving levodopa/carbidopa. Selegiline was significantly superior to placebo on all three principal outcome measures employed: change from baseline in daily levodopa/carbidopa dose, the amount of 'off' time, and patient self-rating of treatment success. Beneficial effects were also observed on other measures of treatment success (e.g., measures of reduced end of dose akinesia, decreased tremor and sialorrhea, improved speech and dressing ability and improved overall disability as assessed by walking and comparison to previous state).

Source: the FDA label for Selegiline Hydrochloride (Apotex Corp.), September 17, 2026. Full label on DailyMed